SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops,…
Category: 6. Business
-
Epcoritamab Plus R-mini-CHOP May Aid in Treatment of Elderly Patients with First-Line DLBCL
Treatment with fixed-duration epcoritamab-bysp (Epkinly) plus dose-attenuated rituximab (Rituxan) plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-mini-CHOP) appeared to be well tolerated and elicited responses in elderly…
Continue Reading
-
Is STAAR Surgical Attractive After Multi Year Share Price Slide And DCF Upside?
-
Wondering whether STAAR Surgical at around $25 a share is a bargain or a value trap? Let us unpack what the market is really pricing in and what the fundamentals say.
-
The stock is roughly flat over the last year at about 0.3% while still up…
Continue Reading
-
-
Berkshire Hathaway (BRK.B) Valuation Check After Steady Share Price Gains
Berkshire Hathaway (BRK.B) quietly keeps doing what it does best, compounding value in the background while the market chases headlines. With the stock grinding higher this year, it is worth unpacking what is driving that steady climb.
See…
Continue Reading
-
Odronextamab Plus CHOP Produces Deep, Potentially Durable Responses in Previously Untreated DLBCL
The CD20 × CD3-directed bispecific antibody odronextamab produced high, potentially durable complete responses (CR) and had a generally manageable safety profile when administered in combination with standard CHOP chemotherapy to patients with…
Continue Reading
-
Rusfertide Continues to Show Strong Results for Polycythemia Vera
Treatment with the hepcidin mimetic rusfertide continued to demonstrate sustained hematocrit control below 45% and high rates of phlebotomy ineligibility through week 52 for patients with polycythemia vera (PV), according to updated findings…
Continue Reading
-
Did Cameco’s (TSX:CCO) Expanded Role in Nuclear Fuel Just Reframe Its Long-Term Investment Narrative?
-
Cameco Corporation recently presented at the Mines and Money @ Resourcing Tomorrow conference in London, where Global Managing Director Dominic Kieran outlined the company’s role in the nuclear fuel supply chain.
-
The presentation…
Continue Reading
-
-
Does Lumen’s New AWS Firewall Product and CTO Shift Reframe Its Cloud Security Ambitions (LUMN)?
-
In early December 2025, Lumen Technologies announced the launch of Lumen Defender Managed Rules for AWS Network Firewall and confirmed upcoming leadership changes, with Executive Vice President and Chief Technology and Product Officer David…
Continue Reading
-
-
Does Lightspeed Commerce’s 79% Five Year Slide Create a Valuation Opportunity in 2025?
-
If you are wondering whether Lightspeed Commerce is finally a bargain after years of volatility, you are not alone. This article is going to dig into whether the current price actually stacks up against its fundamentals.
-
The stock closed at…
Continue Reading
-
-
Capital cities lead, while other cities lag in the EU
Economic growth in the EU has been persistently slower than in the US over the past two decades. Economic growth has been slowing, mainly due to weakening labour productivity growth according to the Draghi…
Continue Reading